SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
SMPL

Simply Good Foods Co (NASDAQ:SMPL)

US · Delayed Price · Currency is USD
Consumer Defensive · Packaged Foods
12.42-0.18 (-1.43%)
 
Market cap
$1.08B
Insider Score
Health Score
Analyst consensus
Listed since
Jul 10, 2017
Insider Score
––Not scored
SMPL Insider Score

Insiders here have filed 6 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.

SMPL analyst forecast

SMPL analyst consensus

Hold4 ratings
Buy 1 Hold 3 Sell 0

Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.

SMPL 12-month price target

$13.33+7.3% upsideaverage of 3 firms
$18.00High
$11.00Low

SMPL ratings mix, last 12 months

Buy Hold Sell

Best analysts covering SMPL

  • Stifel50%success rate · -16.9% avg return · 4 calls
  • Mizuho30%success rate · -23.7% avg return · 10 calls

Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.

SMPL analyst ratings

FirmPrice targetAction
—StifelBuy——Reiterated2026-10-28
JefferiesHold$11.00+12.8%Downgraded2026-10-28
—UBSNeutral——Reiterated2026-10-28
D.A. Davidson—$11.00+5.8%—2026-10-28
Stifel Nicolaus—$18.00+84.6%—2026-10-28
D.A. Davidson—$12.00+17.7%—2026-10-26
—TD CowenHold——Reiterated2026-08-26
—DA DavidsonNeutral——Reiterated2026-07-10
—BernsteinMarket Perform——Downgraded2026-06-03
—UBSNeutral——Reiterated2026-06-02
—Deutsche BankHold——Reiterated2026-04-10
—Stephens & Co.Equal Weight——Downgraded2026-04-10
—StifelBuy——Reiterated2026-04-10
—TD CowenHold——Reiterated2026-04-10
—DA DavidsonNeutral——Reiterated2026-04-10
—UBSNeutral——Reiterated2026-04-10
—Morgan StanleyEqual Weight——Reiterated2026-04-10
—UBSNeutral——Reiterated2026-04-02
—JefferiesBuy——Upgraded2026-03-16
—BernsteinOutperform——Reiterated2025-12-19
—MizuhoOutperform——Reiterated2025-11-12
—UBSNeutral——Reiterated2025-10-24
—JefferiesHold——Reiterated2025-10-22
—UBSNeutral——Reiterated2025-10-08
—JefferiesHold——Reiterated2025-09-04
—MizuhoOutperform——Reiterated2025-07-15
—UBSNeutral——Reiterated2025-07-01
—StifelBuy——Reiterated2025-06-27
—CitigroupBuy——Reiterated2025-06-18
—DA DavidsonNeutral——Reiterated2025-06-09
—MizuhoOutperform——Reiterated2025-04-11
—DA DavidsonNeutral——Reiterated2025-04-11
—Morgan StanleyEqual Weight——Reiterated2025-04-10
—DA DavidsonNeutral——Reiterated2025-04-07
—MizuhoOutperform——Reiterated2025-01-10
—MizuhoOutperform——Reiterated2024-12-09
—CitigroupBuy——Reiterated2024-11-14
—Stephens & Co.Overweight——Reiterated2024-10-23
—DA DavidsonNeutral——Reiterated2024-07-01
—NeedhamBuy——Reiterated2024-06-28
—Deutsche BankHold——Reiterated2024-06-14
—StifelBuy——Reiterated2024-06-14
—NeedhamBuy——Reiterated2024-04-30
—DA DavidsonNeutral——Reiterated2024-04-30
—Morgan StanleyOverweight——Reiterated2024-04-11
—MizuhoBuy——Reiterated2024-04-08
—DA DavidsonNeutral——Reiterated2024-04-05
—MizuhoBuy——Reiterated2024-04-05
—NeedhamBuy——Reiterated2024-04-05
—StifelBuy——Reiterated2024-03-28
—DA DavidsonNeutral——Reiterated2024-03-20
—Morgan StanleyOverweight——Reiterated2024-03-20
—DA DavidsonNeutral——Reiterated2024-01-05
—NeedhamBuy——Reiterated2024-01-05
—Deutsche BankHold——Downgraded2024-01-02
—NeedhamBuy——Reiterated2023-10-25
—NeedhamBuy——Reiterated2023-10-10
—Morgan StanleyOverweight——Upgraded2023-09-18
—Morgan StanleyEqual Weight——Reiterated2023-07-11
—CitigroupBuy——Reiterated2023-07-10

SMPL earnings vs. estimates

QuarterEPS est.EPS actualRevenue est.Revenue actual
2026-01-080.360.39$337.9M$340.2M
2026-04-090.400.45$345.4M$326.0M
2026-07-090.350.42$333.0M$357.0M
2026-10-270.400.44$327.0M$333.3M
2027-01-07Upcoming0.29—$270.8M—
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.